Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

193

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	933,971 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
L01AX03	TEMODAL	B	Temozolomide - 20mg	20mg	Capsule	1,612,611 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 20mg	20mg	Tablet, film coated	440,893,501 L.L
L04AA29	XELJANZ XR	B	Tofacitinib - 11mg	11mg	Tablet, extended release	78,687,316 L.L
N02AJ14	LENIZAK	B	Tramadol HCl - 75mg, Dexketoprofen - 25mg		Tablet, film coated	494,534 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
J01XA02	TARGOCID	B	Teicoplanin - 400mg	400mg	Injectable lyophilised powder for solution+diluent	1,331,748 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 40mg	40mg	Tablet, film coated	440,893,501 L.L
M01AE11	SURGAM	B	Tiaprofenic acid - 300mg	300mg	Tablet	849,308 L.L
N02AX02	TRAMAL	B	Tramadol HCl - 50mg	50mg	Capsule	470,345 L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	L.L
A10BB12	AMARYL	B	Glimepiride - 1mg	1mg	Tablet	231,141 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	933,971 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	21,354,452 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 60mg	60mg	Tablet, film coated	440,893,501 L.L
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	38,773,533 L.L
M01AE17	KETESSE	B	Dexketoprofen (trometamol) - 25mg	25mg	Tablet, film coated	399,121 L.L
N02AX02	TRAMAL 100MG	B	Tramadol HCl - 100mg/2ml	100mg/2ml	Injectable solution	243,235 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 12.5mg	12.5mg	Tablet, controlled release	2,330,541 L.L
B01AA07	SINTROM	B	Acenocoumarol - 4mg	4mg	Tablet	490,183 L.L
H01CC02	CETROTIDE	B	Cetrorelix (acetate) - 0.25mg	0.25mg	Injectable lyophilised powder for solution+diluent	3,420,079 L.L
J01XA02	TARGOCID	B	Teicoplanin - 200mg	200mg	Injectable lyophilised powder for solution+diluent	714,924 L.L

...

193